Evidence map›Paper›PMID 25685931›Full record

ArticleThe Journal of investigative dermatology2015

Keloid Pathogenesis: Potential Role of Cellular Fibronectin with the EDA Domain.

Jonathan P Andrews, Jaana Marttala, Edward Macarak, Joel Rosenbloom, Jouni Uitto

Abstract readComparative StudyLetter
In one paragraph

Article in The Journal of investigative dermatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Poly(l-lactic acid) Scaffold Releasing an αACS applied bio materials · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Keloids: The paradigm of skin fibrosis - Pathomechanisms and treatment.Matrix biology : journal of the International Society for Matrix Biology · 2016
    Review
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Jonathan P AndrewsDepartment of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Jaana MarttalaDepartment of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Edward MacarakDepartment of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA; The Joan and Joel Rosenbloom Research Center for Fibrotic Diseases, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Joel RosenbloomDepartment of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA; The Joan and Joel Rosenbloom Research Center for Fibrotic Diseases, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Jouni UittoDepartment of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Electronic address: jouni.uitto@jefferson.edu.

Funding

TRAINING IN MOLECULAR DERMATOLOGY AND CUTANEOUS CONNECTIVE TISSUE DISEASEST32AR060715 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI UITTO, JOUNI · 2011 to 2015
$728k
NIAMS NIH HHS T32 AR060715NIAMS NIH HHS T32-AR060715
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene Expression RegulationAnimalsBlotting, WesternCells, CulturedEctodysplasinsFibroblastsFibronectinsHumansKeloidMiceReference ValuesRNA, MessengerRoleWound HealingEctodysplasinsEDA protein, humanFibronectinsRNA, Messenger

Identifiers

PMID25685931
PMCPMC4466014

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.